1. Home
  2. ARQQ vs ACHV Comparison

ARQQ vs ACHV Comparison

Compare ARQQ & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$12.10

Market Cap

211.3M

Sector

Technology

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.12

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQQ
ACHV
Founded
2017
N/A
Country
United Kingdom
United States
Employees
91
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.3M
172.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ARQQ
ACHV
Price
$12.10
$5.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$60.00
$14.67
AVG Volume (30 Days)
679.0K
1.4M
Earning Date
05-21-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$381.13
N/A
Revenue Next Year
$212.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.52
$2.00
52 Week High
$62.00
$6.15

Technical Indicators

Market Signals
Indicator
ARQQ
ACHV
Relative Strength Index (RSI) 36.78 53.31
Support Level N/A $4.04
Resistance Level $17.25 $5.30
Average True Range (ATR) 1.61 0.38
MACD -0.28 -0.02
Stochastic Oscillator 3.19 56.82

Price Performance

Historical Comparison
ARQQ
ACHV

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: